Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Ophthalmology therapeutics Market Research Reports

Titlepublishedprice

Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2014

By Global Markets Direct
"...... with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key play......"
24-Dec-2014$2000

Retinal Degeneration - Pipeline Review, H2 2014

By Global Markets Direct
"...... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic deve......"
10-Dec-2014$2000

Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2014

By Global Markets Direct
"...... ovascular / Exudative) Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and feat......"
30-Nov-2014$2000

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2014

By Global Markets Direct
"...... with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key play......"
30-Nov-2014$2000

Allergic Rhino-Conjunctivitis - Pipeline Review, H2 2014

By Global Markets Direct
"...... arative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players invol......"
30-Nov-2014$2000

Dry (Atrophic) Macular Degeneration - Pipeline Review, H2 2014

By Global Markets Direct
"...... complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews......"
30-Nov-2014$2000

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H2 2014

By Global Markets Direct
"...... peutic development for Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecu......"
18-Nov-2014$2000

Viral Conjunctivitis - Pipeline Review, H2 2014

By Global Markets Direct
"...... stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic deve......"
18-Nov-2014$2000

Blepharitis - Pipeline Review, H2 2014

By Global Markets Direct
"...... sment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Blepharitis and......"
18-Nov-2014$2000

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014

By Global Markets Direct
"...... (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also......"
14-Nov-2014$2000

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy